{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:53:05Z","timestamp":1791262385433,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bioorg.2026.110539","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T23:46:43Z","timestamp":1789602403000},"page":"110539","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Design, synthesis, biological evaluation and mechanistic investigation of quinazolinone\u2013hydrazonothioate conjugates against multidrug-resistant bacteria"],"prefix":"10.1016","volume":"182","author":[{"given":"Ayman M.","family":"Sweed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Abdelraof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed H.","family":"Afifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed N.","family":"El-Bayaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadiyah M.","family":"Alshammari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherif S.","family":"Ragab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.110539_bb0005","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Murray","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.bioorg.2026.110539_bb0010","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","article-title":"Global burden of bacterial antimicrobial resistance 1990\u20132021: a systematic analysis with forecasts to 2050","volume":"404","author":"Naghavi","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.bioorg.2026.110539_bb0015","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1093\/jac\/dkm129","article-title":"Evolution of antimicrobial resistance among Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae in Brooklyn, NY","volume":"60","author":"Landman","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bioorg.2026.110539_bb0020","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1177\/001857870504000507","article-title":"Update on resistance among nosocomial gram-negative pathogens to extended-spectrum cephalosporins and fluoroquinolones: results of the antimicrobial resistance management (ARM) program","volume":"40","author":"John","year":"2005","journal-title":"Hosp. Pharm."},{"key":"10.1016\/j.bioorg.2026.110539_bb0025","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jgar.2025.05.008","article-title":"Antimicrobial resistance in Campylobacter spp. focussing on C. jejuni and C. coli\u2013a narrative review","volume":"43","author":"Mohan","year":"2025","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"10.1016\/j.bioorg.2026.110539_bb0030","first-page":"247","article-title":"Increasing antimicrobial resistance of Campylobacter jejuni isolated from paediatric diarrhea cases in a tertiary care hospital of New Delhi, India","volume":"7","author":"Ghosh","year":"2013","journal-title":"J. Clin. Diagn. Res."},{"key":"10.1016\/j.bioorg.2026.110539_bb0035","doi-asserted-by":"crossref","first-page":"5302","DOI":"10.1128\/JB.00239-07","article-title":"Low concentrations of bile salts induce stress responses and reduce motility in Bacillus cereus ATCC 14570","volume":"189","author":"Kristoffersen","year":"2007","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.bioorg.2026.110539_bb0040","article-title":"4(3H)-Quinazolinone: a natural scaffold for drug and agrochemical discovery","volume":"26","author":"Chen","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.110539_bb0045","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s13738-021-02315-8","article-title":"Synthesis and biological evaluation of some 3H-quinazolin-4-one derivatives","volume":"19","author":"Sharaf","year":"2022","journal-title":"J. Iran. Chem. Soc."},{"key":"10.1016\/j.bioorg.2026.110539_bb0050","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1016\/j.bmc.2016.03.031","article-title":"Quinazolines and quinazolinones as ubiquitous structural fragments in medicinal chemistry: an update on the development of synthetic methods and pharmacological diversification","volume":"24","author":"Khan","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110539_bb0055","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.2174\/092986707781058805","article-title":"Molecular hybridization: a useful tool in the design of new drug prototypes","volume":"14","author":"Viegas-Junior","year":"2007","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110539_bb0060","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00253-011-3557-z","article-title":"Exploiting bacterial DNA gyrase as a drug target: current state and perspectives","volume":"92","author":"Collin","year":"2011","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.bioorg.2026.110539_bb0065","article-title":"New quinazolin-4(3H)-one derivatives incorporating hydrazone and pyrazole scaffolds as antimicrobial agents targeting DNA gyrase enzyme","volume":"90","author":"El-Deen","year":"2022","journal-title":"Sci. Pharm."},{"key":"10.1016\/j.bioorg.2026.110539_bb0070","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1080\/13543776.2018.1432596","article-title":"Quinazoline and quinazolinone as important medicinal scaffolds: a comparative patent review (2011\u20132016)","volume":"28","author":"Hameed","year":"2018","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bioorg.2026.110539_bb0075","first-page":"88","article-title":"Overview of albaconazole","volume":"5","author":"Bartroli","year":"2011","journal-title":"Eur. Infect. Dis."},{"key":"10.1016\/j.bioorg.2026.110539_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0188106","article-title":"Identification of isolates of the plant pathogen Leptosphaeria maculans with resistance to the triazole fungicide fluquinconazole using a novel in planta assay","volume":"12","author":"Van de Wouw","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.bioorg.2026.110539_bb0085","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ejmech.2019.03.018","article-title":"4(3H)-Quinazolinone derivatives: promising antibacterial drug leads","volume":"170","author":"Gatadi","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110539_bb0090","doi-asserted-by":"crossref","first-page":"5531","DOI":"10.1016\/j.bmc.2018.09.032","article-title":"Synthesis and evaluation of 2-substituted 4(3H)-quinazolinone thioether derivatives as monoamine oxidase inhibitors","volume":"26","author":"Qhobosheane","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110539_bb0095","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.3987\/COM-09-11659","article-title":"A facile and convenient method to the one-pot synthesis of 2-mercapto-4(3H)-quinazolinones","volume":"78","author":"Nikpour","year":"2009","journal-title":"Heterocycles"},{"key":"10.1016\/j.bioorg.2026.110539_bb0100","article-title":"Hydrazonoyl halides as key precursors for the synthesis of arylazo and arylhydrazo thiazoles","author":"Gomha","year":"2025","journal-title":"Mini-Rev. Org. Chem."},{"key":"10.1016\/j.bioorg.2026.110539_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2025.151872","article-title":"Salicylaldehyde-derived hydrazones: synthesis, characterization, antibacterial activity, antioxidant and anti-inflammatory effects on LPS-induced RAW264.7 macrophage cells, drug-likeness properties, and molecular docking analysis","volume":"766","author":"Demirba\u011f","year":"2025","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bioorg.2026.110539_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22179389","article-title":"Updated information on antimicrobial activity of hydrazide\u2013hydrazones","volume":"22","author":"Popio\u0142ek","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.110539_bb0115","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4103\/0975-7406.129170","article-title":"A review exploring biological activities of hydrazones","volume":"6","author":"Verma","year":"2014","journal-title":"J. Pharm. Bioallied Sci."},{"key":"10.1016\/j.bioorg.2026.110539_bb0120","doi-asserted-by":"crossref","first-page":"4626","DOI":"10.1039\/D0NJ05450J","article-title":"Design, synthesis, biological activities and 3D-QSAR studies of quinazolinone derivatives containing hydrazone structural units","volume":"45","author":"Shao","year":"2021","journal-title":"New J. Chem."},{"key":"10.1016\/j.bioorg.2026.110539_bb0125","article-title":"Design, synthesis, and biological evaluation of N-acyl-hydrazone-linked quinazolinone derivatives with antioxidant, antimicrobial, and anticancer potential","volume":"19","author":"Coand\u0103","year":"2026","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bioorg.2026.110539_bb0130","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4103\/1735-5362.228942","article-title":"Synthesis, antimicrobial evaluation and docking studies of some novel quinazolinone Schiff base derivatives","volume":"13","author":"Nasab","year":"2018","journal-title":"Res. Pharm. Sci."},{"key":"10.1016\/j.bioorg.2026.110539_bb0135","first-page":"1517","article-title":"Design, synthesis, molecular docking ADMET and anti-bacterial activities of some new benzamides and their corresponding quinazolinone derivatives","volume":"65","author":"Ayoob","year":"2022","journal-title":"Egypt. J. Chem."},{"key":"10.1016\/j.bioorg.2026.110539_bb0140","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1134\/S0012500823600463","article-title":"Biochemical basis of the antimicrobial activity of quinazolinone derivatives in the light of insights into the features of the chemical structure and ways of binding to target molecules. A review","volume":"510","author":"Samotrueva","year":"2023","journal-title":"Dokl. Chem."},{"key":"10.1016\/j.bioorg.2026.110539_bb0145","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1039\/D4RA07563C","article-title":"New quinazolone\u2013sulfonate conjugates with an acetohydrazide linker as potential antimicrobial agents: design, synthesis and molecular docking simulations","volume":"15","author":"Kassem","year":"2025","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2026.110539_bb0150","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202400057","article-title":"A literature review on pharmacological aspects, docking studies, and synthetic approaches of quinazoline and quinazolinone derivatives","volume":"357","author":"Ghoneim","year":"2024","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bioorg.2026.110539_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2025.142953","article-title":"New quinazolinone-based heterocyclic compounds as promising antimicrobial agents: development, DNA gyrase B\/topoisomerase IV inhibition activity, and in silico computational studies","volume":"1344","author":"Alsfouk","year":"2025","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.110539_bb0160","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-11516-7","article-title":"Design, synthesis, and antimicrobial evaluation of novel quinazoline piperazine phosphorodiamidate hybrids as potent DNA gyrase inhibitors","volume":"15","author":"Donka","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.110539_bb0165","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/1574-6976.12026","article-title":"Antimicrobial strategies centered around reactive oxygen species\u2013bactericidal antibiotics, photodynamic therapy, and beyond","volume":"37","author":"Vatansever","year":"2013","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.bioorg.2026.110539_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2020.109023","article-title":"The role of reactive oxygen species in the biological activity of antimicrobial agents: an updated mini review","volume":"320","author":"Lam","year":"2020","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bioorg.2026.110539_bb0175","doi-asserted-by":"crossref","first-page":"5011","DOI":"10.1021\/acs.jmedchem.6b00372","article-title":"Structure\u2013activity relationship for the 4(3H)-Quinazolinone antibacterials","volume":"59","author":"Bouley","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110539_bb0180","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ica.2017.03.038","article-title":"Sulfonamide carbonic anhydrase inhibitors: zinc coordination and tail effects influence inhibitory efficacy and selectivity for different isoforms","volume":"470","author":"Ferraroni","year":"2018","journal-title":"Inorg. Chim. Acta"},{"key":"10.1016\/j.bioorg.2026.110539_bb0185","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.biopha.2018.04.021","article-title":"DNA gyrase inhibitors: progress and synthesis of potent compounds as antibacterial agents","volume":"103","author":"Khan","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bioorg.2026.110539_bb0190","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11020371","article-title":"DNA gyrase as a target for quinolones","volume":"11","author":"Spencer","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.bioorg.2026.110539_bb0195","article-title":"New quinazolin-4(3H)-one derivatives incorporating hydrazone and pyrazole scaffolds as antimicrobial agents targeting DNA gyrase enzyme","volume":"90","author":"El-Deen","year":"2022","journal-title":"Sci. Pharm."},{"key":"10.1016\/j.bioorg.2026.110539_bb0200","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.bmcl.2006.12.005","article-title":"Structure\u2013activity relationships of 3-aminoquinazolinediones, a new class of bacterial type-2 topoisomerase (DNA gyrase and topo IV) inhibitors","volume":"17","author":"Tran","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.110539_bb0205","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2011.00034","article-title":"Bacterial carbonic anhydrases as drug targets: toward novel antibiotics?","volume":"2","author":"Supuran","year":"2011","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.110539_bb0210","doi-asserted-by":"crossref","DOI":"10.3390\/metabo7040056","article-title":"An overview of the bacterial carbonic anhydrases","volume":"7","author":"Supuran","year":"2017","journal-title":"Metabolites"},{"key":"10.1016\/j.bioorg.2026.110539_bb0215","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1080\/14728222.2023.2263914","article-title":"An overview of novel antimicrobial carbonic anhydrase inhibitors","volume":"27","author":"Supuran","year":"2023","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.bioorg.2026.110539_bb0220","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2020.598095","article-title":"Quinazolinones as competitive inhibitors of carbonic anhydrase-II (human and bovine): synthesis, in-vitro, in-silico, selectivity, and kinetics studies","volume":"8","author":"Khan","year":"2020","journal-title":"Front. Chem."},{"key":"10.1016\/j.bioorg.2026.110539_bb0225","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2023.2191163","article-title":"Development of novel anilinoquinazoline-based carboxylic acids as non-classical carbonic anhydrase IX and XII inhibitors","volume":"38","author":"Elsayed","year":"2023","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110539_bb0230","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1016\/j.bmcl.2005.03.070","article-title":"Synthesis and structure\u2013activity relationship of 3-phenyl-3H-quinazolin-4-one derivatives as CXCR3 chemokine receptor antagonists","volume":"15","author":"Storelli","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826010758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826010758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:23:55Z","timestamp":1791260635000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826010758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":46,"alternative-id":["S0045206826010758"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110539","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, biological evaluation and mechanistic investigation of quinazolinone\u2013hydrazonothioate conjugates against multidrug-resistant bacteria","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110539","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110539"}}